Leuprorelin acetate Prescribing at HOLDERNESS HEALTH
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
578
Total Quantity
578
NHS Cost
£91.3K
vs National Avg
+1147.2%
HOLDERNESS HEALTH prescribed 578 items of Leuprorelin acetate over the last 12 months at a cost of £91,308 to the NHS. This is 1147.2% above the national average prescribing rate. Leuprorelin acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jul 2026
3
Jul 2026
97
Jul 2026
50
Jul 2026
31
Jul 2026
42
Jul 2026
64
Jul 2026
37
Jul 2026
66
Jul 2026
33
Jul 2026
38
Jul 2026
65
Jul 2026
52
Prescribing Details
| Total Items | 578 |
|---|---|
| Total Quantity | 578 |
| Total NHS Cost | £91,308 |
| Presentations | 5 different forms |
| vs National Average | +1147.2% |
Leuprorelin acetate Prescribing Comparison
| This practice | 578 items |
|---|---|
| National average per practice | 46 items |
| Difference | +1147.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.